You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
Title |
MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma
|
---|---|
Published in |
BMC Cancer, January 2011
|
DOI | 10.1186/1471-2407-11-33 |
Pubmed ID | |
Authors |
Amanda Tivnan, Lorraine Tracey, Patrick G Buckley, Leah C Alcock, Andrew M Davidoff, Raymond L Stallings |
Abstract |
Neuroblastoma is a paediatric cancer which originates from precursor cells of the sympathetic nervous system and accounts for 15% of childhood cancer mortalities. With regards to the role of miRNAs in neuroblastoma, miR-34a, mapping to a chromosome 1p36 region that is commonly deleted, has been found to act as a tumor suppressor through targeting of numerous genes associated with cell proliferation and apoptosis. |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 3% |
Belgium | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 66 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 16 | 23% |
Student > Master | 12 | 17% |
Student > Ph. D. Student | 12 | 17% |
Student > Bachelor | 9 | 13% |
Other | 4 | 6% |
Other | 10 | 14% |
Unknown | 7 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 22 | 31% |
Biochemistry, Genetics and Molecular Biology | 18 | 26% |
Medicine and Dentistry | 13 | 19% |
Engineering | 4 | 6% |
Neuroscience | 2 | 3% |
Other | 4 | 6% |
Unknown | 7 | 10% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 August 2014.
All research outputs
#15,302,068
of 22,757,541 outputs
Outputs from BMC Cancer
#4,106
of 8,276 outputs
Outputs of similar age
#141,810
of 182,685 outputs
Outputs of similar age from BMC Cancer
#27
of 35 outputs
Altmetric has tracked 22,757,541 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,276 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,685 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.